Your browser doesn't support javascript.
loading
Rituximab as a sole steroid-sparing agent in generalized myasthenia gravis: Long-term outcomes.
Kefalopoulou, Zinovia-Maria; Veltsista, Dimitra; Germeni, Alexandra; Lykouras, Dimosthenis; Tsiamaki, Eirini; Chroni, Elisabeth.
Affiliation
  • Kefalopoulou ZM; Department of Neurology, University Hospital of Patras, 26504, Patras, Rio, Greece. zkefalopoulou@gmail.com.
  • Veltsista D; Neuromuscular Centre, University Hospital of Patras, 26504, Patras, Rio, Greece. zkefalopoulou@gmail.com.
  • Germeni A; Department of Neurology, University Hospital of Patras, 26504, Patras, Rio, Greece.
  • Lykouras D; Neuromuscular Centre, University Hospital of Patras, 26504, Patras, Rio, Greece.
  • Tsiamaki E; Department of Neurology, University Hospital of Patras, 26504, Patras, Rio, Greece.
  • Chroni E; Department of Respiratory Medicine, University Hospital of Patras, 26504, Patras, Rio, Greece.
Neurol Sci ; 45(3): 1233-1242, 2024 Mar.
Article in En | MEDLINE | ID: mdl-37831214
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Immunologic Factors / Myasthenia Gravis Limits: Adult / Humans Language: En Journal: Neurol Sci Journal subject: NEUROLOGIA Year: 2024 Type: Article Affiliation country: Greece
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Immunologic Factors / Myasthenia Gravis Limits: Adult / Humans Language: En Journal: Neurol Sci Journal subject: NEUROLOGIA Year: 2024 Type: Article Affiliation country: Greece